NaviFUS Corp.
NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and ot… Read more
Market Cap & Net Worth: NaviFUS Corp. (6872)
NaviFUS Corp. (TWO:6872) has a market capitalization of $36.46 Million (NT$1.21 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #46005 globally and #2040 in its home market, demonstrating a -10.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NaviFUS Corp.'s stock price NT$17.05 by its total outstanding shares 70745000 (70.75 Million).
NaviFUS Corp. Market Cap History: 2025 to 2026
NaviFUS Corp.'s market capitalization history from 2025 to 2026. Data shows growth from $42.98 Million to $36.46 Million (0.00% CAGR).
NaviFUS Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NaviFUS Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6872 by Market Capitalization
Companies near NaviFUS Corp. in the global market cap rankings as of March 19, 2026.
Key companies related to NaviFUS Corp. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
NaviFUS Corp. Historical Marketcap From 2025 to 2026
Between 2025 and today, NaviFUS Corp.'s market cap moved from $42.98 Million to $ 36.46 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$36.46 Million | -15.17% |
| 2025 | NT$42.98 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NaviFUS Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $36.46 Million USD |
| MoneyControl | $36.46 Million USD |
| MarketWatch | $36.46 Million USD |
| marketcap.company | $36.46 Million USD |
| Reuters | $36.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.